[Device treatment approaches targeting the sympathetic nervous system in patients with resistant hypertension].
A large percentage of patients with hypertension do not meet guideline blood pressure goal, which increases cardiovascular morbidity and mortality. Involvement of sympathetic nervous system has been recognized but our intervention for the system was limited to pharmacological therapy. The new interventions, such as intra-renal artery ablation and baroreflex activation therapies, directed toward the sympathetic nervous system, were intensely examined in various areas of cardiovascular disease. These interventions are promising with some conflicting results.